Insight

Filippo Alongi

Jun 18, 2025, 15:32

Filippo Alongi Shared Study on Real-World Safety and Feasibility of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients

Filippo Alongi, Professor at University of Brescia, shared a post on X about his recent article, published in Cancers Journal:

“Our experience of optimal feasibility and no significant toxicity with 1.5 T MR-guided daily adapted RT in 1000 cases is now available in detail here.”

Title: The Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter Center

Journal: Cancers

Authors: Chiara De-Colle, Michele Rigo, Andrea Gaetano Allegra, Luca Nicosia, Niccolò Giaj-Levra, Edoardo Pastorello, Francesco Ricchetti, Carolina Orsatti, Andrea Romei, Nicola Bianchi, Riccardo Filippo Borgese, Antonio De Simone, Davide Gurrera, Stefania Naccarato, Gianluisa Sicignano, Ruggero Ruggieri, Filippo Alongi

Read the full article.

Filippo Alongi

More posts featuring Filippo Alongi on OncoDaily.

Andrea Gaetano Allegra Andrea Romei Antonio De Simone cancer Cancers Journal Carolina Orsatti Chiara De-Colle Davide Gurrera Edoardo Pastorello Filippo Alongi Francesco Ricchetti Gianluisa Sicignano Luca Nicosia Michele Rigo Niccolò Giaj Levra Nicola Bianchi OncoDaily Oncology Riccardo Filippo Borgese Ruggero Ruggieri Stefania Naccarato University of Brescia

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More